Achieve Life Sciences (ACHV) Accounts Payables (2010 - 2026)
Achieve Life Sciences (ACHV) posted Accounts Payables of $806000.0 for Q1 2026, up 9975.0% on a QoQ basis from $8000.0 in Q4 2025, and down 51.33% year-over-year from $1.7 million in Q1 2025.
Achieve Life Sciences (ACHV) Accounts Payables (2010 - 2026) Analysis & Trends
Achieve Life Sciences' Accounts Payables history runs 17 years deep, the most recent figure standing at $806000.0 for Q1 2026.
- Quarterly Accounts Payables fell 51.33% year-over-year to $806000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $806000.0 (down 51.33% YoY) and the FY2025 annual result came in at $8000.0, down 99.59% from the prior year.
- Accounts Payables was $806000.0 for Q1 2026 at Achieve Life Sciences, up from $8000.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $2.0 million in Q4 2024 and bottomed at $8000.0 in Q4 2025.
- A 5-year average of $902411.8 and a median of $656000.0 in 2022 frame the typical range for Accounts Payables.
- Peak annual rise in Accounts Payables reached 343.97% in 2025, while the deepest fall reached 99.59% in 2025.
- Achieve Life Sciences' Accounts Payables stood at $1.7 million in 2022, then plunged by 62.77% to $618000.0 in 2023, then jumped by 215.53% to $2.0 million in 2024, then plunged by 99.59% to $8000.0 in 2025, then jumped by 9975.0% to $806000.0 in 2026.
- Business Quant data shows ACHV's Accounts Payables at $806000.0 in Q1 2026, $8000.0 in Q4 2025, and $1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - | 806,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 806,000.00 |
| Dec 31, 2025 | 8,000.00 |
| Sep 30, 2025 | 1.94 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | 1.95 Mn |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 550,000.00 |
| Mar 31, 2024 | 373,000.00 |
| Dec 31, 2023 | 618,000.00 |
| Sep 30, 2023 | 638,000.00 |
| Jun 30, 2023 | 361,000.00 |
| Mar 31, 2023 | 1.06 Mn |
| Dec 31, 2022 | 1.66 Mn |
| Sep 30, 2022 | 412,000.00 |
| Jun 30, 2022 | 656,000.00 |
| Mar 31, 2022 | 418,000.00 |
| Dec 31, 2021 | 841,000.00 |
| Sep 30, 2021 | 815,000.00 |
| Jun 30, 2021 | 575,000.00 |